KLASSEN PRESTON (President & Head of R & D) sold 46.6% of their position (31.45K shares) of REGULUS THERAPEUTICS INC. on the open market
Open‑market sale worth $39.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/15/2025ACC: 0000950170-25-005880
Officer· President & Head of R & D
Since Jun 2023
-31.45K
Net shares
Net seller
$39.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
31.45K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−31.45K
Price / share
$1.26
Trade value
$39.72K
% of position
46.6%
1/13/2025
67.50K→36.05K
Total
Net shares
−31.45K
Net value
-$39.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/13/2025 | S · Sale | −31.45K | $1.26 | $39.72K | 46.6% | 67.50K | 36.05K |
| Total | −31.45K | -$39.72K | ||||||
Derivative Transactions0
No derivative transactions reported